Sentinel Lymph Node Evaluations

Advances in Dermatology

Volumn 23, Issue , 2007, Pages 47-60

  Zitelli, John A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; HISTORY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; METASTASIS; METHODOLOGY; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; SURVIVAL;

HISTORY, 20TH CENTURY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 36049048310     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2007.07.006     Document Type: Review

References (45)

1. Halstead W.S. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Arch Surg 20 (1894) 497
2. Halstead W.S. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46 (1907) 1
3. Pharis D.B., and Zitelli J.A. The management of regional lymph nodes in cancer. Br J Dermatol 149 (2003) 919-925
4. Pharis D.B. Cutaneous melanoma: therapeutic lymph node and elective lymph node dissections, lymphatic mapping, and sentinel lymph node biopsy. Dermatol Ther 18 (2005) 397-406
5. Fisher B., Montague E., Redmond C., et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial. Cancer 39 (1977) 2827-2839
6. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer; an overview of the randomized trials. N Engl J Med 333 (1995) 144-155
7. Fisher B., and Fisher E.R. Barrier functions of lymph node to tumor cells and erythrocytes. Cancer 20 (1967) 1907-1913
8. Veronesi U., Adamus J., Bandiera D.C., et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 297 (1977) 627-630
9. Sim F.H., Taylor W.F., Ivins J.C., et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: preliminary results. Cancer 41 (1978) 948-956
10. Balch C.M., Soong S.J., Bartolucci A.A., et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224 (1996) 255-263
11. Cascinelli N., Morabito A., Santinami M., et al. Immediate or delayed dissection of regional lymph nodes in patients with melanoma of the trunk: a randomized trial. WHO melanoma programme. Lancet 351 (1998) 793-796
12. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
13. Kirkwood J.M., Strawderman M.H., Ernstoff M.S., et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14 (1996) 7-17
14. Kirkwood J.M., Ibrahim J.G., Sondak V.K., et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of Intergroup Trial E1690/S9111/C9190. J Clin Oncol 18 (2000) 2444-2458
15. Verma S., Quirt I., McCready D., et al. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer 106 (2006) 1431-1442
16. Otley C.C., and Zitelli J.A. Review of sentinel lymph node biopsy and systemic interferon for melanoma: promising but investigational modalities. Dematol Surg 26 (2000) 177-180
17. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006) 1307-1317
18. Thomas J.M. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial. J Clin Oncol 23 (2005) 9443-9444
19. Thomas J.M. Letter. Sentinel-node biopsy in melanoma. N Engl J Med 356 (2007) 418
20. A'Hern R.P. Letter. Sentinel-node biopsy in melanoma. N Engl J Med 356 (2007) 418
21. Grichnik J.M. Letter. Sentinel-node biopsy in melanoma. N Engl J Med 356 (2007) 418-419
22. Moehrle M., Schippert W., Rassner R.C., et al. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival. Dermatol Surg 30 (2004) 1319-1328
23. Roka F., Kittler H., Cauzig P., et al. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. Br J Cancer 92 (2005) 662-667
24. Retsas S., Henry K., Mohammed M.Q., et al. Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a consort of 1284 patients. Eur J Cancer 38 (2002) 511-516
25. Vuylsteke R.J., van Leeuwen P.A., Muller M.G., et al. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 21 (2003) 1057-1065
26. De Mascarel I., Soubeyran I., MacGrogan G., et al. Immunohistochemically detected lymph node metastases from breast carcinoma. Cancer 103 (2005) 1319-1322
27. Chagpar A., Middlteon L.P., Sahim A.A., et al. Clinical outcome of patents with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103 (2005) 1581-1586
28. O'Connell J.B., Maggard M.A., and Ko C.Y. Colon cancer survival rates with the New American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 96 (2004) 1420-1425
29. Redston M., Compton C.C., Miedema B.W., et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of cancer and Leukemia Group B Trial 80001. J Clin Oncol 24 (2006) 878-883
30. Pearlman N.W., McCarter M.D., Frank M., et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg 192 (2006) 878-881
31. Starz H., Balda B.R., Kramer K.U., et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its climical relevance for patients with melanoma. Cancer 91 (2001) 2110-2120
32. Carlson G.W., Murray D.R., Lyles R.H., et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?. Ann Surg Oncol 10 (2003) 575-581
33. van Akkooi A.C., Bouwhuis M.G., van Geel A.N., et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 33 (2007) 102-108
34. Spanknebel K., Coit D.G., Bieligk S.C., et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 29 (2005) 305-317
35. van Akkooi A.C., de Wilt J.H., Verhoef C., et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?. Ann Oncol 17 (2006) 1578-1585
36. Li W., Stall A., Shivers S.C., et al. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining on sentinel lymph nodes of patients with melanoma. Ann Surg 231 (2000) 795-803
37. Thomas J.M. Caution with sentinel node biopsy in cutaneous melanoma. Br J Surg 93 (2006) 129-130
38. Morton D.L., Cochran A.J., and Thompson J.F. Sentinel node biopsy in melanoma. [letter]. N Engl J Med 356 (2007) 419-420
39. Kelley S.W., and Cockerell C.J. Sentinel lymph node biopsy as an adjunct to management of histologically difficult to diagnose melanocytic lesions: a proposal. J Am Acad Dermatol 42 (2000) 527-530
40. Ridolfi R.L., Rosen P.P., and Thaler H. Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance. Cancer 39 (1977) 164-171
41. McCarthy S.W., jPalmer A.A., Bale P.M., et al. Naevus cells in lymph nodes. Pathology 6 (1974) 351-358
42. Lohmann C.M., Coit D.G., Brady M.S., et al. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 26 (2002) 47-55
43. Otley C.C., and Zitelli J.A. Review of sentinel lymph node biopsy and systemic interferon for melanoma: promising but investigational modalities. Dermatol Surg 26 (2006) 177-180
44. Michl C., Starz H., Bachter D., et al. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol 149 (2003) 763-769
45. Harwood M., Wu H., Tanabe K., et al. Metastatic basal cell carcinoma diagnosed by sentinel lymph node biopsy. J Am Acad Dermatol 53 (2005) 475-478